YOU WERE LOOKING FOR :China and Pharmaceutical Expansion
Essays 361 - 390
An overview of this company that develops and markets prescription pharmaceutical drugs and dietary supplements is presented in a ...
p. PG). Consumers are becoming nonplussed, and therefore resistant, to all the elaborate marketing schemes found in todays market...
In forty pages this research study examines the international pharmaceutical industry in an overview of global acquisitions, merge...
This twenty three page paper provides a detailed look at the conference proceedings and the complicated issues that emerged. Drug...
In thirty pages this report considers European and American approaches to pharmaceutical advertising in an examination of similari...
In twenty pages this paper examines SmithKline Beecham Pharmaceuticals in an overview of its financial performance and industry st...
In six pages this paper examines the development of marketing and business strategies for pharmaceutical and health industries as ...
not in conflict with models of corporate governance such as Milton Friedmans shareholder wealth maximisation model. Other interest...
Proctor and Gamble pharmaceuticals are a lively division. This is a company where it was once the role of the sales representative...
18.5 percent profit margin, more than four times that of all other industries" (Barry, 2002, May). With that money the drug indust...
invested equity is larger than the required equity rate of return (Johnson, 2002-2003). The DCF method is used when prospective di...
the "government should subsidize prescription drug spending for all 40 million Americans over the age of 65 - whether they need it...
likely not endear the FDA to elderly people who at this point cannot afford medication and are forced to go over the border to pur...
The drug that ImClone hopes to hang its hat on is Erbitux, which was developed to target and block Epidermal Growth Factor Recepto...
demand and unemployment. When Ronald Reagan entered office, he initiated his famous "supply side" economic theory with its "trickl...
just came on the market. This paper will demonstrate that this difficult career can be rewarding as it provides a worthwhile livin...
industry average is 9.91%, and for Pfizer is still lower, but gives different results, this time of 8.54. This may also be seen as...
and it sells Zantac under the Warner-Lambert name, another acquisition (Hoovers, 2002). It was Warner-Lambert who manufactured Lip...
(or at least to help reduce the side effects of this immune deficiency disease). The reality of the situation is, however, ...
is relatively cheap or expensive when compared t the rest of the market. The lower the number the faster the company will earn its...
this once giant drug company is definitely suffering a mid-life crisis. Background Merck, which is headquartered in Whiteho...
drug can work under "ideal" conditions rather than a real-world environment, tend to take place in controlled artificial environme...
to expand their capacity for research and basically, to increase their overall productivity (Borchardt, 2000). The analysis fram...
care issues will explore the relationship between European think tanks and the multinational pharmaceutical companies, specificall...
marketing within the pharmaceutical industry: Social and cultural forces/consumer behavior. Factors to be considered include: * Th...
to beat the competitors to market with the latest drugs (Active Media, 2001). Thus is why it is intensely research and development...
In six pages this paper discusses the pharmaceuticals industry in terms of increased government regulation with Glaxo Wellcome's A...
the cost and regardless of who pays for the care that individuals receive. Though grossly oversimplified, the skeletal structure ...
caused a greater demand for information, as well as product. That information is made available through the increased and strategi...
In ten pages this paper examines the drug manufactured by Eisai Pharmaceutical, Inc. along with the marketing strategies that affe...